HCA Healthcare price target raised to $322 from $308 at RBC Capital

RBC Capital raised the firm’s price target on HCA Healthcare to $322 from $308 and keeps an Outperform rating on the shares. The company set a solid tone for providers this year with Q4 results and initial 2024 guidance coming in ahead of expectations, the analyst tells investors in a research note. The elevated utilization continues to weigh on carriers, but RBC continues to see a strong setup for providers this year, particularly names best positioned to capture outpatient migration of elective volume, the firm added.